Fabio Gelsomino

20PUBLICATIONS
121CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 26, 2026
Young Age Is Associated with Improved Survival After Resection of Non-Metastatic Pancreatic Ductal Adenocarcinoma.

|Sep 26, 2026
Colorectal Cancer in Younger and Elderly Patients: A Real-World Analysis from the Modena Cancer Center.

|Sep 23, 2026
Tumor Immune Microenvironment and Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer: Results From the STAR-01 Study Cohort.

|Nov 04, 2025
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.

Pascal Hammel, Jean-Philippe Metges, Teresa Macarulla Mercade

|Oct 06, 2025
Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer.

Ming Lei, Michael J Overman, Jin Yao

|Jun 13, 2025
New Frontiers of Biomarkers in Metastatic Colorectal Cancer: Potential and Critical Issues.

Bianca Medici, Stefania Benatti, Massimo Dominici

Pageof 4

Frequent Collaborators

7 joint publications

Ingrid Garajovà

4 joint publications

Andrea Spallanzani

3 joint publications

Massimo Dominici

3 joint publications

Annarita Pecchi